News for '-euan'

Serum Institute seeks DCGI nod for Covovax

Serum Institute seeks DCGI nod for Covovax

Rediff.com29 Oct 2021

There were no safety concerns arising from the study data and Covovax is safe and immunogenic in the adult population, Prakash Kumar Singh, Director, Government and Regulatory Affairs at the Serum Institute of India (SII), is learnt to have said in the application sent to the DCGI.

Govt panel seeks additional data from SII on Covovax

Govt panel seeks additional data from SII on Covovax

Rediff.com28 Nov 2021

The Serum Institute of India (SII) had put in an application to the Drugs Controller General of India (DCGI) in October for grant of market authorisation of Covovax for restricted use in emergency situations.

Covid-19 could be the boost Indian pharma cos need

Covid-19 could be the boost Indian pharma cos need

Rediff.com20 Sep 2020

The western world had largely considered India to be a production hub, and also, a good potential geography for clinical trials, and a big market. But in Covid-19 research, Indian companies and government researchers are also researching new drug candidates and potential vaccines, says Prosenjit Datta.

Forcing DNA test on unwilling party violates privacy: SC

Forcing DNA test on unwilling party violates privacy: SC

Rediff.com1 Oct 2021

The Supreme Court Friday said DNA test is not to be directed as a matter of routine but only in deserving cases as forcing an unwilling party to undergo a DNA test infringes the personal liberty and right to privacy of an individual.

Govt orders 66 cr Covishield doses from SII by Dec

Govt orders 66 cr Covishield doses from SII by Dec

Rediff.com9 Sep 2021

The development comes after Prakash Kumar Singh, the Director, Government and Regulatory Affairs at SII, informed the Union health ministry that the firm would be able to supply 20.29 crore doses of Covishied in the month of September.

'COVID-19 vaccine will be made in India'

'COVID-19 vaccine will be made in India'

Rediff.com12 Jun 2020

'I can say with confidence that any future SARS-CoV-2 vaccine, developed anywhere in the world, would have to be manufactured in India, if it is to be affordable and of high quality.'

COVID-19 Vaccine: 4 months from lab to jab

COVID-19 Vaccine: 4 months from lab to jab

Rediff.com8 Jun 2021

'Almost 70 per cent production time of a vaccine is dedicated to quality control, which is done through several hundred tests.'

Rolls-Royce chairman quits due to illness

Rolls-Royce chairman quits due to illness

Rediff.com22 Jun 2004

Aerospace giant Rolls-Royce announced the resignation of its chairman, Euan Baird, 66, due to a long convalescence after he suffered a stroke in December.

Why Modi visited Serum's Covid vaccine unit

Why Modi visited Serum's Covid vaccine unit

Rediff.com10 Dec 2020

The PM's visit would signal a strong intent towards making sure India becomes a beneficiary as vaccines become a massively traded commodity in the coming years.

'It'll take 3-4 years to vaccinate 80% of population'

'It'll take 3-4 years to vaccinate 80% of population'

Rediff.com11 Jan 2021

'We are hoping by March, the government allows us to export and give it to the private market.'

What I learnt from fighting COVID-19

What I learnt from fighting COVID-19

Rediff.com3 Aug 2020

'Social distancing, wearing masks and hygiene should be practised more strictly.'' 'People should not assemble in close spaces as the micro droplets may hang in the air and can last for a longer time.'

Can COVID-19 live in your fridge?

Can COVID-19 live in your fridge?

Rediff.com22 Jul 2020

'The majority of transmission will be via people who are within two metres of one another.' 'The closer you are, the more likely that you'll be infected.'

Raghuram Rajan was 'forced to quit'

Raghuram Rajan was 'forced to quit'

Rediff.com19 Jun 2016

Raghuram Rajan joked he wasn't expecting to win any votes or Facebook 'likes' in the position.